11 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
.
The primary purpose of the Audit Committee is to oversee our financial reporting processes on behalf of our Board. The Audit Committee’s functions
DEF 14A
navs y1ue895zg8e5
27 Apr 21
Definitive proxy
4:15pm
10-K
3y09s i0m66pxfo6xscp
23 Mar 21
Annual report
4:26pm
424B4
bf68tzetw2
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1/A
r7b9fifrqsdhhcffmv
9 Oct 20
IPO registration (amended)
5:26pm
S-1
0hxuftuphxliyd7ro9
25 Sep 20
IPO registration
5:27pm
DRS
9ht1 czw4c
26 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next